Benign Grade 3, 4, or 5 Pathological stage PET scan Surgical margin Antibody drug conjugate Sarcoma Minimal residual disease Liquid tumor Palliation Partial remission Carcinoma Leukemia Lymphoma Definitive treatment CTCAE Complementary therapy Checkpoint inhibitor Maintenance chemotherapy Tyrosine kinase inhibitors (TKIs) Complete remission Recurrence or relapse Performance status Adenocarcinoma ECOG performance status Clinical stage TNM staging system Cancer Multiple myeloma Tumor Monoclonal antibody Adjuvant treatment Neoadjuvant treatment Cure Chemotherapy Refractory Active surveillance Cellular therapy Benign Grade 3, 4, or 5 Pathological stage PET scan Surgical margin Antibody drug conjugate Sarcoma Minimal residual disease Liquid tumor Palliation Partial remission Carcinoma Leukemia Lymphoma Definitive treatment CTCAE Complementary therapy Checkpoint inhibitor Maintenance chemotherapy Tyrosine kinase inhibitors (TKIs) Complete remission Recurrence or relapse Performance status Adenocarcinoma ECOG performance status Clinical stage TNM staging system Cancer Multiple myeloma Tumor Monoclonal antibody Adjuvant treatment Neoadjuvant treatment Cure Chemotherapy Refractory Active surveillance Cellular therapy
(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.
Benign
Grade 3, 4, or 5
Pathological stage
PET scan
Surgical margin
Antibody drug conjugate
Sarcoma
Minimal residual disease
Liquid tumor
Palliation
Partial remission
Carcinoma
Leukemia
Lymphoma
Definitive treatment
CTCAE
Complementary therapy
Checkpoint inhibitor
Maintenance chemotherapy
Tyrosine kinase inhibitors (TKIs)
Complete remission
Recurrence or relapse
Performance status
Adenocarcinoma
ECOG performance status
Clinical stage
TNM staging system
Cancer
Multiple myeloma
Tumor
Monoclonal antibody
Adjuvant treatment
Neoadjuvant treatment
Cure
Chemotherapy
Refractory
Active surveillance
Cellular therapy